Nitric oxide-active compounds modulate the intensity of glutamate-evoked responses in the globus pallidus

In this study, the effects of microiontophoretically applied NO-active compounds on glutamate(GLU)-evoked responses were investigated in globus pallidus (GP) neurons from anesthetized rats. Most GP cells were excited by S-nitrosoglutathione (SNOG), an NO donor, whereas administration of Nω-nitro-L-arginine methyl ester (L-NAME), a NOS inhibitor, induced a decrease of GP neurons activity. Nearly all neurons responding to SNOG and/or L-NAME showed significant excitatory responses to the administration of iontophoretic GLU. In these cells, the changes induced by NO-active drugs in the magnitude of GLU-evoked responses were used as indicators of NO modulation. When an NO-active drug and GLU wer…

Comparison of effects of Valproate and the newly synthesized Valproil-L-Tryptophan on epileptiform activity in rat brain slices

Effects of nitric oxide and cGMP-active compounds on neuronal activity of substantia nigra pars reticulata: a rat in vivo study

Sintesi di un nuovo derivato dell’acido valproico ed effetti in un modello sperimentale di epilessia ippocampale nel ratto

Evidences of cannabinoids-induced modulation of paroxysmal events in an experimental model of partial epilepsy in the rat

Different studies have been shown a clear anticonvulsant activity exerted by cannabinoids (CB) through the CB1 receptor activation. The purpose of this study was to evaluate, in an in vivo experimental model of temporal lobe epilepsy (maximal dentate gyrus activation - MDA) in the rat, the protective effect of (R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl) pyrrolo[1,2,3-de]-1,4-benzoxazin-6-Yl]-1-naphthalenylmethanone (WIN 55,212-2, CB agonist) alone or in combination with N-(piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (AM251, selective CB1 antagonist). Pre-treatment with AM251 (1 mg kg-1, 30 min interval) dramatically reduced the signif…